Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

December 1, 2026

Conditions

Ulcerative Colitis (UC)Fecal CalprotetinFIT

Interventions

DIAGNOSTIC_TEST

fecal calprotectin

patients will accpet test of FC combine FIT

All Listed Sponsors

collaborator

Qilu Hospital of Shandong University (Qingdao)

OTHER

collaborator

Dezhou Hospital Qilu Hospital of Shandong University

OTHER

collaborator

Weihai Municipal Hospital

OTHER

collaborator

Liaocheng People's Hospital

OTHER

collaborator

Jining First People's Hospital

OTHER

lead

Qilu Hospital of Shandong University

OTHER

NCT07111572 - Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis | Biotech Hunter | Biotech Hunter